Literature DB >> 15560983

Technology for high-throughput screens: the present and future using zebrafish.

Donald R Love1, Franz B Pichler, Andrew Dodd, Brent R Copp, David R Greenwood.   

Abstract

The zebrafish is a popular vertebrate model organism with similar organ systems and gene sequences to humans. Zebrafish embryos are optically transparent enabling organ visualisation, which can be complemented with gene expression analysis at the transcript and protein levels. Furthermore, zebrafish can be treated with small molecules and drugs in a microtitre plate format for high-throughput analysis and for the identification and validation of drugs. High-throughput methodologies for use in zebrafish include phenotype-based visualisation, transcript studies using low-density DNA microarrays and proteomic analysis. These technologies offer significant whole-organism biological value in the drug discovery and drug development pipeline.

Entities:  

Mesh:

Year:  2004        PMID: 15560983     DOI: 10.1016/j.copbio.2004.09.004

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  23 in total

1.  A reference growth curve for nutritional experiments in zebrafish (Danio rerio) and changes in whole body proteome during development.

Authors:  P Gómez-Requeni; L E C Conceição; A-E Olderbakk Jordal; I Rønnestad
Journal:  Fish Physiol Biochem       Date:  2010-04-30       Impact factor: 2.794

Review 2.  Zebrafish models in neuropsychopharmacology and CNS drug discovery.

Authors:  Kanza M Khan; Adam D Collier; Darya A Meshalkina; Elana V Kysil; Sergey L Khatsko; Tatyana Kolesnikova; Yury Yu Morzherin; Jason E Warnick; Allan V Kalueff; David J Echevarria
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

3.  High content screening in zebrafish speeds up hazard ranking of transition metal oxide nanoparticles.

Authors:  Sijie Lin; Yan Zhao; Tian Xia; Huan Meng; Zhaoxia Ji; Rong Liu; Saji George; Sijing Xiong; Xiang Wang; Haiyuan Zhang; Suman Pokhrel; Lutz Mädler; Robert Damoiseaux; Shuo Lin; Andre E Nel
Journal:  ACS Nano       Date:  2011-08-25       Impact factor: 15.881

Review 4.  Zebrafish xenotransplantation as a tool for in vivo cancer study.

Authors:  Beibei Zhang; Chao Xuan; Yunxi Ji; Weiming Zhang; Daogang Wang
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

5.  Sample preparation optimization of insects and zebrafish for whole-body mass spectrometry imaging.

Authors:  Lianlian Ma; Qingrong Xie; Mingyi Du; Yudi Huang; Yingying Chen; Dong Chen; Yizhu Xu; Hanhong Xu; Xinzhou Wu; Zhibin Yin
Journal:  Anal Bioanal Chem       Date:  2022-05-04       Impact factor: 4.142

Review 6.  Advances in zebrafish chemical screening technologies.

Authors:  Jonathan R Mathias; Meera T Saxena; Jeff S Mumm
Journal:  Future Med Chem       Date:  2012-09       Impact factor: 3.808

Review 7.  Zebrafish: an in vivo model for nano EHS studies.

Authors:  Sijie Lin; Yan Zhao; André E Nel; Shuo Lin
Journal:  Small       Date:  2012-12-03       Impact factor: 13.281

Review 8.  Hierarchical approaches for systems modeling in cardiac development.

Authors:  Russell A Gould; Lina M Aboulmouna; Jeffrey D Varner; Jonathan T Butcher
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2013-03-05

9.  Zebrafish high-throughput screening to study the impact of dissolvable metal oxide nanoparticles on the hatching enzyme, ZHE1.

Authors:  Sijie Lin; Yan Zhao; Zhaoxia Ji; Jason Ear; Chong Hyun Chang; Haiyuan Zhang; Cecile Low-Kam; Kristin Yamada; Huan Meng; Xiang Wang; Rong Liu; Suman Pokhrel; Lutz Mädler; Robert Damoiseaux; Tian Xia; Hilary A Godwin; Shuo Lin; André E Nel
Journal:  Small       Date:  2012-11-23       Impact factor: 13.281

10.  Zebrafish models for ectopic mineralization disorders: practical issues from morpholino design to post-injection observations.

Authors:  Mohammad Jakir Hosen; Olivier M Vanakker; Andy Willaert; Ann Huysseune; Paul Coucke; Anne De Paepe
Journal:  Front Genet       Date:  2013-05-08       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.